Cerebrolysin
Speech Therapy Combined With Cerebrolysin in Enhancing Nonfluent Aphasia Recovery After Acute Ischemic Stroke: ESCAS Randomized Pilot Study
The ESCAS pilot found a 14.805-point greater mean 90-day Western Aphasia Battery–Aphasia Quotient gain with Cerebrolysin plus speech therapy, with uncertain generalizability and functional benefit.